1. He Z, Ke Y. Precision screening for esophageal squamous cell carcinoma in China. Chin J Cancer Res. 2020;32(6):673-82.
2. Zhang J, Wang JL, Zhang CY, Ma YF, Zhao R, Wang YY. The prognostic role of FZD6 in esophageal squamous cell carcinoma patients. Clin Transl Oncol. 2020;22(7):1172-9.
3. Jing X, Yang F, Shao C, Wei K, Xie M, Shen H, et al. Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol Cancer. 2019;18(1):157.
4. Chen F, Chu L, Li J, Shi Y, Xu B, Gu J, et al. Hypoxia induced changes in miRNAs and their target mRNAs in extracellular vesicles of esophageal squamous cancer cells. Thorac Cancer. 2020;11(3):570-80.
5. Wang Y, Xie Z, Lu H. Significance of halofuginone in esophageal squamous carcinoma cell apoptosis through HIF-1alpha-FOXO3a pathway. Life Sci. 2020;257:118104.
6. Macedo-Silva C, Miranda-Goncalves V, Lameirinhas A, Lencart J, Pereira A, Lobo J, et al. JmjC-KDMs KDM3A and KDM6B modulate radioresistance under hypoxic conditions in esophageal squamous cell carcinoma. Cell Death Dis. 2020;11(12):1068.
7. Vaupel P, Mayer A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev. 2007;26(2):225-39.
8. Muz B, de la Puente P, Azab F, Azab AK. The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia (Auckl). 2015;3:83-92.
9. Mao Y, Wang Y, Dong L, Zhang Y, Zhang Y, Wang C, et al. Hypoxic exosomes facilitate angiogenesis and metastasis in esophageal squamous cell carcinoma through altering the phenotype and transcriptome of endothelial cells. J Exp Clin Cancer Res. 2019;38(1):389.
10. Liu M, An H, Zhang Y, Sun W, Cheng S, Wang R, et al. Molecular analysis of Chinese oesophageal squamous cell carcinoma identifies novel subtypes associated with distinct clinical outcomes. EBioMedicine. 2020;57:102831.
11. van Uden P, Kenneth NS, Rocha S. Regulation of hypoxia-inducible factor-1alpha by NF-kappaB. Biochem J. 2008;412(3):477-84.
12. Yuan H, Yan M, Zhang G, Liu W, Deng C, Liao G, et al. CancerSEA: a cancer single-cell state atlas. Nucleic Acids Res. 2019;47(D1):D900-D8.
13. Liberzon A, Birger C, Thorvaldsdottir H, Ghandi M, Mesirov JP, Tamayo P. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1(6):417-25.
14. Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.
15. Akanji MA, Rotimi D, Adeyemi OS. Hypoxia-Inducible Factors as an Alternative Source of Treatment Strategy for Cancer. Oxid Med Cell Longev. 2019;2019:8547846.
16. Harris BH, Barberis A, West CM, Buffa FM. Gene Expression Signatures as Biomarkers of Tumour Hypoxia. Clin Oncol (R Coll Radiol). 2015;27(10):547-60.
17. Yang L, West CM. Hypoxia gene expression signatures as predictive biomarkers for personalising radiotherapy. The British journal of radiology. 2019;92(1093):20180036.
18. Shou Y, Yang L, Yang Y, Zhu X, Li F, Xu J. Identification of Signatures of Prognosis Prediction for Melanoma Using a Hypoxia Score. Front Genet. 2020;11:570530.
19. Yang Y, Li Y, Qi R, Zhang L. Constructe a novel 5 hypoxia genes signature for cervical cancer. Cancer Cell Int. 2021;21(1):345.
20. Winther M, Alsner J, Tramm T, Nordsmark M. Hypoxia-regulated gene expression and prognosis in loco-regional gastroesophageal cancer. Acta Oncol. 2013;52(7):1327-35.
21. Zhu YH, Yang F, Zhang SS, Zeng TT, Xie X, Guan XY. High expression of biglycan is associated with poor prognosis in patients with esophageal squamous cell carcinoma. International journal of clinical and experimental pathology. 2013;6(11):2497-505.
22. Tang L, Chen Y, Peng X, Zhou Y, Jiang H, Wang G, et al. Identification and Validation of Potential Pathogenic Genes and Prognostic Markers in ESCC by Integrated Bioinformatics Analysis. Front Genet. 2020;11:521004.
23. Yang L, Cui R, Li Y, Liang K, Ni M, Gu Y. Hypoxia-Induced TGFBI as a Serum Biomarker for Laboratory Diagnosis and Prognosis in Patients with Pancreatic Ductal Adenocarcinoma. Lab Med. 2020;51(4):352-61.
24. Liu Z, Liu S, Guo J, Sun L, Wang S, Wang Y, et al. Identification and Analysis of Key Genes Driving Gastric Cancer Through Bioinformatics. Genet Test Mol Biomarkers. 2021;25(1):1-11.
25. Saetang J, Chonpathompikunlert P, Sretrirutchai S, Roongsawang N, Kayasut K, Voravuthikunchai SP, et al. Anti-cancer effect of engineered recombinant interleukin 18. Adv Clin Exp Med. 2020;29(10):1135-43.
26. Tsuboi K, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Manda R, et al. Serum interleukin-12 and interleukin-18 levels as a tumor marker in patients with esophageal carcinoma. Cancer Lett. 2004;205(2):207-14.
27. Xiao W, Tang P, Sui Z, Wu X, Yang Y, Zhu N, et al. Identification of a Hypoxia-Related Gene Signature and Establishment of a Nomogram for Predicting Prognosis in Esophageal Squamous Cell Carcinoma. https://www.researchsquare.com/article/rs-1008316/v1.